头孢哌酮钠舒巴坦钠不良反应分析与预测模型构建.pdf

文档介绍：昆明医科大学学报 2021，42 （6） ：139~145 DOI: .2095-
Journal of Kunming ， so as to construct the prediction model of adverse reactions， and provide reference for the
rational application ofcefoperazone Sodium and Sulbactam Sodium in clinical practice. Methods From January
2015 to June 2020，222 adverse reaction reports of cefoperazone sodium and sulbactam sodium for injection in the
Kunming City Adverse Drug Reaction Report Monitoring Database were extracted as the observation group. During
the same period，no adverse reaction occurred when using cefoperazone sodium and sulbactam sodium for injection，
The 250 responding cases were used as the control group. The clinical data of the two groups of patients were
collected，and the relationship between the factors was analyzed through correlation; the related factors of adverse

[收稿日期] 2021 − 03 − 26
[基金项目] 昆明市卫生科技基金资助项目（2020-16-01-001）；昆明市科技计划重点基金资助项目（2017-1-S-16355，
2017-1-S-14333）
[作者简介] 刘幸（1985～），男，云南昆明人，硕士，副主任药师，主要从事临床药学的研究工作。
[通信作者] 马玲，E-mail：******@ 昆明医科大学学报 第 42 卷
reactions were analyzed by multivariate logistic regression，and the prediction of adverse reactions was constructed
according to the results Model。 Evaluate the effectiveness of predi